C-reactive protein and interleukin-6 mean levels were significantly higher in patients with rheumatic heart disease not taking long-acting penicillin compared to patients with rheumatic heart disease taking long-acting penicillin and to the control group. This evidence concerns the gene CRP and rheumatic heart disease.